{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:08:04Z","timestamp":1761919684547,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.msard.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T13:01:38Z","timestamp":1365253298000},"page":"391-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Varicella vaccination after fingolimod: A case report"],"prefix":"10.1016","volume":"2","author":[{"given":"Joseph R.","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2013.03.002_bib6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2013.03.002_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1083-8791(00)70004-8","article-title":"Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients","volume":"6","author":"Arvin","year":"2000","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.msard.2013.03.002_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.03.002_bib10","first-page":"166","article-title":"Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings","volume":"87","author":"Diaz","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.msard.2013.03.002_bib3","unstructured":"Duquette P, Kappos L, Cohen JA, Francis G, Collins W, Zhang-Auberson L, et al. Long-tem safety of fingolimod in relapsing MS: phase 2 and 3 analyses. In: Proceedings of the 24th annual meeting of the consortium of multiple sclerosis centers. Montreal, Quebec; 2011."},{"key":"10.1016\/j.msard.2013.03.002_bib21","unstructured":"Francis G, Kappos L, O'Connor P, Collins W, Zhang-Auberson L, de Vera A, et al. Lymphocytes and fingolimod\u2014temporal pattern and relationship with infections. In: Proceedings of the 26th Congress of the European Committee for the treatment and research in multiple sclerosis. Gothenberg, Sweden; 2010."},{"key":"10.1016\/j.msard.2013.03.002_bib13","series-title":"Fields virology","first-page":"591","article-title":"Varicella-zoster virus","author":"Gelb","year":"1985"},{"key":"10.1016\/j.msard.2013.03.002_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0891-5520(05)70268-3","article-title":"Live-attenuated varicella vaccine","volume":"15","author":"Gershon","year":"2001","journal-title":"Infectious Disease Clinics of North America"},{"key":"10.1016\/j.msard.2013.03.002_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era","volume":"4","author":"Gourishankar","year":"2004","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.msard.2013.03.002_bib4","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1212\/WNL.0b013e3182735d24","article-title":"Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod","volume":"79","author":"Gross","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.03.002_bib9","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on immunization practices","volume":"57","author":"Harpaz","year":"2008","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.msard.2013.03.002_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.03.002_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/516514","article-title":"Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts","volume":"176","author":"LaRussa","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.msard.2013.03.002_bib17","first-page":"467","article-title":"Herpes zoster and the stage and prognosis of HIV-1 infection","volume":"73","author":"McNulty","year":"1997","journal-title":"Genitourinary Medicine"},{"key":"10.1016\/j.msard.2013.03.002_bib20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.wnl.0000327609.57688.ea","article-title":"FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis","volume":"71","author":"Mehling","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.03.002_bib14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/oxfordjournals.aje.a115828","article-title":"Assessment of a school exclusion policy during a chickenpox outbreak","volume":"133","author":"Moore","year":"1991","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.msard.2013.03.002_bib8","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.msard.2013.03.002_bib5","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e3182735d00","article-title":"Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod","volume":"79","author":"Ratchford","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2013.03.002_bib16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1988.00380070065016","article-title":"Varicella-zoster infection in adult cancer patients. A population study","volume":"148","author":"Rusthoven","year":"1988","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.msard.2013.03.002_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3476(97)70140-9","article-title":"Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother","volume":"131","author":"Salzman","year":"1997","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.msard.2013.03.002_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/infdis\/jis334","article-title":"Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population","volume":"206","author":"Tseng","year":"2012","journal-title":"Journal of Infectious Diseases"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034813000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034813000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:36:18Z","timestamp":1761899778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034813000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2211034813000175"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2013.03.002","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Varicella vaccination after fingolimod: A case report","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}